RUNX1 and myeloproliferative neoplasm: In addition to frequent ASXL1 mutations, a significant association of EZH2 mutations with RUNX Family Transcription Factor 1 (RUNX1) mutations has been observed in MDS and MDS/MPN patients [25,48,60].